Intestinal Microbiota Promotes Psoriasis-Like Skin Inflammation by Enhancing Th17 Response
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68378041%3A_____%2F16%3A00470791" target="_blank" >RIV/68378041:_____/16:00470791 - isvavai.cz</a>
Alternative codes found
RIV/61388971:_____/16:00464813 RIV/00216208:11130/16:10327968 RIV/00064211:_____/16:N0000023
Result on the web
<a href="http://dx.doi.org/10.1371/journal.pone.0159539" target="_blank" >http://dx.doi.org/10.1371/journal.pone.0159539</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1371/journal.pone.0159539" target="_blank" >10.1371/journal.pone.0159539</a>
Alternative languages
Result language
angličtina
Original language name
Intestinal Microbiota Promotes Psoriasis-Like Skin Inflammation by Enhancing Th17 Response
Original language description
Psoriasis is a chronic inflammatory skin disease in which Th17 cells play a crucial role. Since indigenous gut microbiota influences the development and reactivity of immune cells, we analyzed the link among microbiota, T cells and the formation of psoriatic lesions in the imiquimod-induced murine model of psoriasis. To explore the role of microbiota, we induced skin inflammation in germ-free (GF), broad-spectrum antibiotic (ATB)-treated or conventional (CV) BALB/c and C57BL/6 mice. We found that both mice reared in GF conditions for several generations and CV mice treated with ATB were more resistant to imiquimod-induced skin inflammation than CV mice. The ATB treatment dramatically changed the diversity of gut bacteria, which remained stable after subsequent imiquimod application; ATB treatment resulted in a substantial increase in the order Lactobacillales and a significant decrease in Coriobacteriales and Clostridiales. Moreover, as compared to CV mice, imiquimod induced a lower degree of local and systemic Th17 activation in both GF and ATB-treated mice. These findings suggest that gut microbiota control imiquimod-induced skin inflammation by altering the T cell response.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
PLoS ONE
ISSN
1932-6203
e-ISSN
—
Volume of the periodical
11
Issue of the periodical within the volume
7
Country of publishing house
US - UNITED STATES
Number of pages
13
Pages from-to
—
UT code for WoS article
000380169600065
EID of the result in the Scopus database
2-s2.0-84979608000